{"name":"JCR Pharmaceuticals Co., Ltd.","slug":"jcr-pharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"jcr.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"JR-141","genericName":"JR-141","slug":"jr-141","indication":"Metachromatic leukodystrophy (MLD)","status":"phase_3"},{"name":"JR-141 or Idursulfase","genericName":"JR-141 or Idursulfase","slug":"jr-141-or-idursulfase","indication":"Hunter syndrome (mucopolysaccharidosis II, MPS II) with central nervous system involvement","status":"phase_3"}]}],"pipeline":[{"name":"JR-141","genericName":"JR-141","slug":"jr-141","phase":"phase_3","mechanism":"JR-141 is a recombinant human arylsulfatase A enzyme designed to cross the blood-brain barrier and replace deficient enzyme activity in lysosomal storage disorders.","indications":["Metachromatic leukodystrophy (MLD)"],"catalyst":""},{"name":"JR-141 or Idursulfase","genericName":"JR-141 or Idursulfase","slug":"jr-141-or-idursulfase","phase":"phase_3","mechanism":"JR-141 is a recombinant idursulfase enzyme that replaces deficient iduronate-2-sulfatase to break down glycosaminoglycans in Hunter syndrome.","indications":["Hunter syndrome (mucopolysaccharidosis II, MPS II) with central nervous system involvement"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNRG12S3NpMEktUmxVUjBCdlhJRFljTjNZbUhFVkZWd05OcVVvTFFNTVdUSDNzTW1BMHQ3U3VjejB1bGlSYTAzQ3k4OFZSa1Q3dHBMbDB1LXRQZHh3Tjl1YVB6LV9hakhBM1BudWRKT3NIOUYtY0t2TUJoWFl4ZHgzUkdwb0g4U2xncEtJOEQ5OExrZVNWT051YTF0QTQwU3lFSFczNS1kZDhwZjZZdnUyRHR1YTU0UVBWZHRDbVJxcDRGU3N4SUxNNGs5Yk90V3JGbEhrRzc3dENOeVlDNC1NVEJWS3hOckZZUkYtaXRPX1RwdWRiTmZib21QcVpJYWM?oc=5","date":"2026-01-13","type":"deal","source":"Citeline News & Insights","summary":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","headline":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNZ0FMLVhyRmt2V3RiYXhxcENRdkYyYU51LTRWWGhndzE4M0U5eWw4NzAzeXZpN0tIWUk2TjFxcDVmZThtTkNWcnNIeWF3TU9BWXZFaUlyd254UFR1NGMzOVlSMGNzN3dQanFhWTFWQk9YVGNRbzRkN25EOU1yNlZiOE5ZbWU2d2xIOVVLRkpOYTI0ZWUwLVJwZTJjRTFiUVl4R1ZMRlFvcWQ4aTRtTVpnVEpLcnY3NVVVVFpJUVQxdw?oc=5","date":"2026-01-08","type":"pipeline","source":"BioSpace","summary":"JCR Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - BioSpace","headline":"JCR Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxOQWJjbXUtX0pIZGFmWHVrNW5CSTJDYjIzVWFfMFFXZ1ZBQW5lYlFSaFpCdFo5UzFUdi1zUVBNcU5IN19DWUozbXlDWW9hZUdwUk96VGkxSEoyOFM5TVBkX0taY05nd2xRMmw5enlqUkN4V2ZVb0Rxd3JOVVVWWkd2RXpSM2JlcUpha29QRjBKSmFRbFltY0xyaHQ4clA2eVotOHNVZXhDWVA1VVZlMW9YR1hYX3E2VF8tYlBqcnowUWJ6am03d2UyemgtWllpMTl4YlVMTEFwVGpBN3k1aVAxdTBmc3RldVFRVDViaF96LUVYS3lHNmlvS0tUZHNwMVRUSmlzN19QWWpkQWEybnVTMGR5TDlieWZmckJNMDZTcG52eG8?oc=5","date":"2025-12-24","type":"deal","source":"Business Wire","summary":"Italfarmaco and JCR Pharmaceuticals Announce Commercialisation Agreement for Givinostat in Japan and Strategic Collaboration in Rare Disease - Business Wire","headline":"Italfarmaco and JCR Pharmaceuticals Announce Commercialisation Agreement for Givinostat in Japan and Strategic Collabora","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxONlFLbnNHbFZ3TkJrc2YtZ3FsRThMNW1aaHp1d1U0SVVGV09ZLWRXa1BmYVkzSks5SVVaMlAyMnROb0tFeXhLQmFoME15SFcwd1FyMzdZSHRzQXhNZGJqSGE4NDI1Q3loODl5emQzWnlMNmExcTQ1QWtYOGlzekY1d0R0VGV1THJjQTlzc2Z3V0xQMVE1d1Y3bmdrWjN2Um5OQUEzOUhZcXFGOHczVlIwVll5UkVtb2hvY2UtaFlOS3M?oc=5","date":"2025-11-17","type":"pipeline","source":"Fierce Biotech","summary":"Breaking Barriers and Crossing Borders: JCR Pharma Launches into Next 50 Years of Innovation with Global Alliances - Fierce Biotech","headline":"Breaking Barriers and Crossing Borders: JCR Pharma Launches into Next 50 Years of Innovation with Global Alliances","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNSHU0aGQ5S2lQRGNLWERTYkFMUkp1MlVGMXpLR0hHenl3Vk9od3AwcmJJVXF2emp2WmR1Uk1MbjdYLV9mamZoR25CRF9aZ19rTlZMUlJnT0tVWWIwSm5qaF9udkpZLUdFaVVJN1JiZHFKWFZtTWE0U1JyUUlfRV9hMzI4a0Q1a3JlZ2F5NzE2cTFKS08tVndwd1FCdXZTN1BuTWNvWEEyUHJQY1diUVRVeTJkSFBwcXlyWnU4b3RqWjVYM2dvS1BzLWhaTEhWNFBET2IyVjdDVDQ3STBUTFE4?oc=5","date":"2025-10-03","type":"pipeline","source":"BioPharma APAC","summary":"JCR Pharmaceuticals Grants Menagen Exclusive Rights to Commercialise Fabry Therapy Across MENAT Region - BioPharma APAC","headline":"JCR Pharmaceuticals Grants Menagen Exclusive Rights to Commercialise Fabry Therapy Across MENAT Region","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOb3J5ak1QUkRhMEs0VGFkNEpad2tNOEtkS2gtRjAzVWQ2a1BKQkpnS2xZUXM2TlQ0b1JfcTIzUzZxNWVZNWhTUjJaQTZkOWZSREtmaVNXNXFMQWFrNXJSa3prOWZxMVJMRTE5Z3NibEdYaHFKYUw5d2I3Z1ozRXdiV3RXN0p5ZTVDVEJ6TjRrTko2N2dmQzJDV19ZM1dsbUdnQTRUM3ZwaXJDdi1GVTRMcWdGTHg3NDY5a2g1ajZudVBtYWdSQmY4Qk4wN0U4bFl1LXB1Z0Z3N1dOR3BJWjlNZzE1MzVNQTRlcWFEU2hQb3ZFbU9zWlQwNV9mdGZZQ05zM2FxLVZoc2Z3YjJ2VmJQQ2kxS2pDQ0c2cWRGMS10S25zVm9wd0E?oc=5","date":"2025-10-01","type":"pipeline","source":"Business Wire","summary":"JCR Pharmaceuticals Announces Licensing Agreement with Menagen to Commercialize Agalsidase Beta BS I.V. Infusion [JCR] Across Nine MENAT Markets - Business Wire","headline":"JCR Pharmaceuticals Announces Licensing Agreement with Menagen to Commercialize Agalsidase Beta BS I.V. Infusion [JCR] A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFByN0dVYkdxQ3hJUkktZUk4OFRBZ21hVXJnY2lJWU9Na3gzeDRNRHVZZHdFQmpuRlRHd2VLc0hJSTcxMmppSHZuTmdYc2dvQThNMVdj?oc=5","date":"2025-07-15","type":"pipeline","source":"FirstWord Pharma","summary":"JCR, Acumen join forces to develop brain-penetrant Alzheimer's therapeutic - FirstWord Pharma","headline":"JCR, Acumen join forces to develop brain-penetrant Alzheimer's therapeutic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOMDJZS2o5TGRmSlRGRDFjaGxtbThuUWI0WmZhOUstZGdJRGlxSHBkOVZ0aWxLdFYwXzRhWUw5Wk85Q1RoV2V0aU9hNUJ4T0lvMEJBd2NvUndGSGVwYkkwZEUwdzB3S0ptb0dSVWdTSVZOc25tVWtzRF90eDhqTHB5UDBtZDE3d1VBM3QyR3lrNzd6UHpUZnYyYlRqUElycExNb0E?oc=5","date":"2025-07-15","type":"deal","source":"Fierce Biotech","summary":"Acumen taps JCR’s blood-brain barrier tech for $555M Alzheimer’s deal - Fierce Biotech","headline":"Acumen taps JCR’s blood-brain barrier tech for $555M Alzheimer’s deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQMWNvNzRfeHZlbUlsTTZUQWkwd2hxNnYxYTdVTldoM0t2ZTFfS3BHME9RZG12VTRHWFZ3SVcwUnZmSGdwSzkweFVhZW43RV9QQ0lQeWN3UWU1RzVIaHJIbkVOWGtrU2tkNV9UM2VaRUJFNUp5aFo0ZGZuYkJrYm9VWXBYYkJMWkcyRFlKNEN3WXVzRzBZOWxseS1IZlZOV3IxQ0E?oc=5","date":"2025-07-15","type":"deal","source":"BioCentury","summary":"Sino Biopharma acquires Lanova in rare China-China takeout - BioCentury","headline":"Sino Biopharma acquires Lanova in rare China-China takeout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxOemw3Z0l5TmFZSW5ET1Nfa3hKV3JZWjlBSWR1NGZyRnN1aWtIRmFEU25YX3dka1FKN1liZURNS0dqZWV2TEd6c2RnT3JCOVhPQU9sUTJEM0d6aU5yVjlncU00NnpvMzF0dnlQTkJ1QVV5NnJ6R1lTLWJBNzlydGpCSHcxb0RKdkw5cVY1YkJfZEgzcjNUSnBYTFdsYXB4YjJNRmRkQkd2TXAwcmhOcGlXdW1CM1dsOXQ5dWV3T0Ixd3dZTkoxb0hnLUxyb0NTR2lsd2xTaU1CR1VrQQ?oc=5","date":"2025-07-10","type":"deal","source":"BioSpectrum Asia","summary":"Japan's JCR Pharma licenses gene therapy platform to AstraZeneca Rare Disease unit for $825 M - BioSpectrum Asia","headline":"Japan's JCR Pharma licenses gene therapy platform to AstraZeneca Rare Disease unit for $825 M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxQTDkteFRWak9LUEZUZy1oZ2hoc1Z0Q1YyUlAtVHBkZHBzbXV0WE9tNExwUEs5SHI5UF9VbEkwNVVRQVVCRHBMSHZEMXExZUpQTDcwYjBuN3Y2OGdHUE93SFZsTVhaMjYtUUJNbEh3RVJiRHZqWHpYSGhfTlluZk9fNHQ5UG1iRlMwWXJodlpsSkxOeEI4ZTI2TjFTYTFrdm55Z0FSMmpMY19VRVJGSFd5NGk3a0NTVGZzUi01ejh0c0paUHBJMC1DZ0pJaUhsdjJ5cDlBRWdjTUxlMllvUXNISHAwUWZZbklJRVI2R09qY25sdVhiUkdrc2EyWVRqQzZIUm1sX2RZTVFaNUpCOXc?oc=5","date":"2025-07-08","type":"deal","source":"BioSpace","summary":"JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines - BioSpace","headline":"JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxOUlZNcDZjYWxVbTZwRktTWmtnVERhMWFOa2Y1SE4yTVNaUGRwdnN4NDlpdXB3WExWcWhBU1h4ZlRjMUY0UE9NdEJsZUQtUzVzWUV0M29pcTZlb3VLTXdlWi1HQ055b3Rvei1GQmVHS1dXTjJ3a2t4YTNYWl9QcFFWUXB6Ny1BMVAyX2ZXWER3UUtKX3p1akh4bmFhY1R4UEs2UUpNN09SMmhnWjNwRTRleVNfUEdMdUFESW9UbkRGLXBOeURuZm1WQzRlRnNhb2NtRFJXbjkyMlZSSkpTTmt6blQ1X3JxNGRiaGsyVjNvYw?oc=5","date":"2025-04-21","type":"pipeline","source":"CRISPR Medicine News","summary":"Press Release Service: Advanced Therapy Medicinal Products Global Strategic Business Report 2025, with Profiles of Bluebird Bio, Gilead Sciences, JCR Pharmaceuticals, Kolon TissueGene, MediPost, Organ","headline":"Press Release Service: Advanced Therapy Medicinal Products Global Strategic Business Report 2025, with Profiles of Blueb","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}